Overweight Trials in Birmingham, United States
Conditions / Overweight / Birmingham, United States
Research into Overweight spans multiple therapeutic approaches and trial phases.
32 total trials for this combination
Showing top 10 of 32 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01601704 | Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study) | TERMINATED | PHASE3 |
| NCT01112839 | Reducing Breast Cancer Recurrence With Weight Loss | COMPLETED | NA |
| NCT07533175 | AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight | RECRUITING | — |
| NCT07282600 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes | RECRUITING | — |
| NCT04657003 | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight | COMPLETED | PHASE3 |
| NCT03574597 | Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity | COMPLETED | PHASE3 |
| NCT07392190 | A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin | RECRUITING | — |
| NCT02019264 | A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors | COMPLETED | PHASE4 |
| NCT03058029 | Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes | UNKNOWN | NA |
| NCT02634268 | INtervention Study In overweiGHT Patients With COPD | COMPLETED | NA |